Industry Payment Guides

Controlled Substance Telehealth: Processing for ADHD and Ketamine Care

Learn how ketamine telehealth payment processing works, what underwriters check in prescribing protocols, and how to bill ADHD and TRT care safely.

White prescription bottle tipped over with assorted white, blue, red and yellow pills and capsules spilling onto a blue surface

Photo: Pixabay

On this page 8 sections
  1. Why Controlled Substance Prescribing Raises Processor Risk
  2. Federal and State Rules for Telemedicine Prescribing
  3. What Underwriters Want to See in Prescribing Protocols
  4. Ketamine Telehealth Payment Processing vs. ADHD and Testosterone Care
  5. Billing Models That Avoid "Pay-for-Prescription" Red Flags
  6. Surviving Processor Audits and Network Inquiries
  7. Choosing a Controlled Substance Telehealth Payment Processor
  8. Next Steps

Key takeaways

  • Clinics that prescribe controlled substances online get the closest processor review because the payment, the visit and the prescription are closely linked.
  • Federal and state telemedicine prescribing rules change often, so underwriters want written protocols and proof that you track current requirements.
  • Charge for clinical care regardless of the clinician's decision. Never charge for a prescription or promise a medication.
  • Keep licenses, prescribing records and dispute files organized so you can answer an audit within days.

Ketamine telehealth payment processing is one of the hardest approvals in healthcare payments. ADHD and testosterone programs face nearly the same scrutiny. When a clinic prescribes controlled substances online, the bank behind its merchant account takes on regulatory, reputational and chargeback risk at the same time. This guide explains why processors treat these clinics so cautiously and how telemedicine prescribing rules affect underwriting. It also covers what your prescribing protocols and billing model need to show to get approved and stay approved.

This article is general information, not legal or regulatory advice. Telemedicine prescribing rules change often. Confirm current requirements with qualified healthcare counsel before you launch or change a program.

Why Controlled Substance Prescribing Raises Processor Risk

Most telehealth clinics are already classified as high risk. For background, see our guide on why telehealth merchant accounts are considered high risk. Prescribing controlled substances adds another layer of risk.

An acquiring bank's main concerns are:

  • Regulatory exposure. Controlled substances are regulated under federal and state law. If a clinic prescribes improperly, the bank that processed its payments can be drawn into the matter.
  • Diversion concerns. Medications with misuse potential attract some patients who want the drug rather than the care. A model that makes prescriptions seem easy to get looks like a diversion risk.
  • Pay-for-prescription perception. If the payment appears tied to receiving a medication, card networks and banks may view the transaction as a sale of a controlled substance instead of a fee for medical services.
  • Chargebacks. Patients who are denied a prescription, patients who cancel subscriptions and people using stolen cards all generate disputes. Recurring billing increases the volume.
  • Sudden rule changes. A shift in federal or state policy could leave part of a clinic's patient base unservable with little notice. That can lead to refunds, cancellations and possibly closure.

None of this means you can't accept cards. It means your application has to show that a licensed clinician makes a genuine medical decision and that your payment flow reflects that.

Federal and State Rules for Telemedicine Prescribing

Federal law restricts prescribing controlled substances over the internet. Federal telemedicine prescribing rules for controlled substances have changed in recent years and may change again. State laws add their own requirements on top of federal law.

Your processor will care a great deal about where these rules stand today, and their status may have changed since this article was written. Before you launch or expand a program, confirm the following with healthcare counsel and current official guidance:

  • Whether a prior in-person evaluation is currently required for the medications you prescribe
  • Whether any additional registration or recordkeeping requirements apply
  • How current rules treat patients who began care under earlier rules
  • Whether requirements differ depending on the medication's classification
  • What each state where you have patients requires beyond federal law

State rules can be stricter than federal rules. States may set their own standards for establishing a provider-patient relationship through telehealth, restrict certain medications, or require prescribers to check a prescription drug monitoring program (PDMP). Your counsel can tell you which requirements apply in your states.

Underwriters don't expect you to predict how federal policy will change. They do expect a written plan for what your clinic will do if the rules shift, including how you will transition or refer existing patients.

What Underwriters Want to See in Prescribing Protocols

A controlled substance telehealth payment processor will ask about clinical operations in much more detail than most merchants expect. Have these materials ready before you apply.

Licensing and Registration

  • State medical licenses for every prescriber, mapped to the states where you see patients
  • Federal and state controlled substance registrations that match how and where your clinicians prescribe, as required
  • Ownership disclosure, including any management services organization (MSO) and professional corporation structure
  • Names and licensing of pharmacy partners, if you route prescriptions to specific pharmacies

Clinical Protocols

  • A written intake and evaluation process, including whether visits are synchronous video or audio
  • Screening criteria and the conditions under which a clinician will decline to prescribe
  • PDMP check procedures, where applicable
  • Follow-up and monitoring schedules for ongoing prescriptions
  • Policies on dose changes, early refill requests and lost medication
  • Referral pathways for patients who need in-person care

Marketing and Website

Underwriters review your website and ads as closely as your paperwork. Expect pushback on:

  • Language that promises a diagnosis or a prescription
  • "Same-day meds" or other speed-focused messaging
  • Prices presented as the price of a medication rather than a visit or program
  • Any health or efficacy claims about the medications

A clean site shows clinician credentials, states clearly that prescribing is at the clinician's discretion, publishes refund and cancellation terms, and lists contact information.

Ketamine Telehealth Payment Processing vs. ADHD and Testosterone Care

These three categories share the controlled-substance problem, but underwriters approach each one a little differently. Legal classifications can change, so confirm current status with counsel.

CategoryTypical Billing PatternWhat Draws Underwriter Attention
Ketamine programsHigher-ticket packages, intake fees, multi-session programsPrepaid packages, at-home dosing, monitoring and safety protocols
ADHD careRecurring monthly visits, lower individual ticketsStimulant prescribing, diversion risk, growth-driven marketing
Testosterone (TRT)Subscriptions bundling visits, labs and sometimes medicationLab requirements, performance or bodybuilding marketing, bundled pricing

Ketamine Programs

Ketamine programs often sell multi-session packages up front, which creates future delivery risk. If the clinic stops operating before the sessions are delivered, the bank may absorb chargebacks for care that was paid for but never received. Expect questions about package size, how far in advance you collect payment, and your refund policy for unused sessions.

At-home ketamine models get extra review. Underwriters will want to know how dosing is monitored, whether a support person must be present during sessions, how medication is dispensed and shipped, and what happens when a patient reports an adverse event. Running in-clinic and at-home options under one merchant account can complicate the review, so describe both models clearly in your application.

ADHD Telehealth Merchant Accounts

Common ADHD stimulants are among the more tightly controlled medications, and banks look closely at online stimulant prescribing. An ADHD telehealth merchant account application should emphasize three things:

  • How thorough the diagnostic evaluation is
  • How you handle patients who request specific stimulants
  • What happens when a clinician recommends a non-stimulant or no medication

Recurring billing is normal in ADHD care. Underwriters will check that the subscription pays for ongoing clinical management, not for refills.

Testosterone Telehealth Payment Processing

Testosterone telehealth payment processing usually involves subscriptions that bundle visits, lab work and sometimes medication or supplies. Underwriters look for required baseline and follow-up labs, clinician review of results, and marketing that stays medical rather than performance-focused. If your clinic also offers peptides or other adjacent products, disclose them. Mixing product lines on one account without disclosure can lead to termination. MannyPay's peptide merchant services page covers that category separately.

Billing Models That Avoid "Pay-for-Prescription" Red Flags

How you structure payments signals how you practice medicine. The principle is simple: the patient pays for clinical care, and the clinician's decision doesn't change what they owe for that care.

Red FlagSafer Structure
Charging only if a prescription is writtenFlat visit fee charged regardless of outcome
Pricing pages listing a stimulant by name with a monthly pricePricing for evaluation, follow-ups and program membership
Medication cost bundled with no visibilityPharmacy bills medication separately, or bundled items are itemized and disclosed
Ad hoc refunds only when a prescription is deniedPublished policy covering denials, cancellations and unused sessions
Subscriptions that renew without noticePre-renewal reminders and easy online cancellation

If you choose to refund patients who aren't prescribed, publish that policy and apply it consistently. Our article on telehealth refunds when the doctor denies the prescription walks through the options.

A few more practical points:

  • Card on file. Use clear authorization language for recurring charges and no-show fees. See our guide to card-on-file billing for virtual visits.
  • Descriptors. Use a billing descriptor patients will recognize. Unfamiliar descriptors lead to "I don't recognize this charge" disputes.
  • Fraud screening. Stolen cards are a real problem for controlled-substance programs. 3-D Secure authentication and identity verification at intake reduce your exposure.
  • Never miscode or split. Don't process controlled-substance care through another business's merchant account or under a misleading category code. That is transaction laundering. It can get you placed on the MATCH list, which can prevent you from getting a merchant account elsewhere.

Surviving Processor Audits and Network Inquiries

Approval is only the first step. Controlled-substance clinics should expect ongoing monitoring, periodic reviews and occasional information requests, sometimes with short deadlines.

Keep this audit binder current:

  1. Up-to-date licenses and registrations for every prescriber
  2. Your current telemedicine prescribing policy, with the date you last reviewed it against federal and state rules
  3. Your contingency plan in case telemedicine prescribing rules change
  4. Current website and ad copy, plus a log of marketing changes
  5. Monthly chargeback and refund reports, with explanations for any spikes
  6. Pharmacy partner agreements
  7. A sample of de-identified transaction records showing visit-based billing

When you respond to disputes or audits, share only the minimum protected health information needed. Our guides on winning telehealth chargebacks without exposing PHI and on whether your payment processor is HIPAA compliant explain how.

If your processor asks questions, answer quickly and completely. Unanswered information requests can lead to held funds or account closure.

Choosing a Controlled Substance Telehealth Payment Processor

General-purpose payment platforms often restrict telehealth, especially when controlled substances are involved. Our breakdown of Stripe, PayPal and Square telehealth rules explains why. A dedicated high-risk merchant account is usually the more stable option.

When you compare providers, ask:

  • Do they underwrite controlled-substance telehealth specifically, or only telehealth in general?
  • What reserves, rolling holds or volume limits might apply? Get current terms in writing.
  • Do they support recurring billing through gateways such as Authorize.net or NMI?
  • Can they provide a virtual terminal for phone-based payments alongside online checkout?
  • Who do you contact when an audit request arrives?

MannyPay offers high-risk merchant accounts and works with telehealth and online pharmacy businesses. Approval depends on underwriting, and not every clinic will qualify.

Next Steps

Before you apply, get your licenses, prescribing protocols, contingency plan, billing structure and website copy in order. Clinics with clean documentation and visit-based billing give underwriters a clear reason to approve them.

When you're ready, request a free merchant account quote. A MannyPay specialist will respond within one business day to review your program and discuss options.

About the author

MannyPay Editorial Team

Beyond the Swipe's editorial desk researches the publication's guides and news and cites its sources in every article. Articles reviewed by a named MannyPay editor carry that editor's byline.

This article is for general educational purposes and is not legal, tax or financial advice. Card network rules and state laws change; confirm current requirements for your business.

Related reading